Related Experiment Video
Updated: Apr 12, 2026

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Neonatal jaundice: phototherapy
Paul Woodgate1, Luke Anthony Jardine
1Department of Neonatology, Mater Mothers' Hospital, Brisbane, Australia.
Insights
This systematic review examines hospital phototherapy for newborn jaundice. It analyzes various light wavelengths, intensities, doses, and treatment start times to determine optimal effectiveness and safety in term and preterm infants.
Area of Science:
- Neonatal Medicine
- Pediatric Phototherapy Research
- Evidence-Based Pediatrics
Background:
- Neonatal jaundice affects a significant percentage of term (50%) and preterm (80%) infants.
- Jaundice results from bilirubin deposition, often due to increased red blood cell breakdown or reduced bilirubin excretion.
- Most cases of newborn jaundice are transient, typically resolving within 1-2 weeks.
Purpose of the Study:
- To systematically review the effects of different light parameters in hospital phototherapy for unconjugated hyperbilirubinemia in infants.
- To evaluate the impact of varying light wavelengths, intensities, total doses, and initiation thresholds on treatment outcomes.
- To assess the safety and effectiveness of phototherapy interventions for neonatal jaundice.
Main Methods:
- A systematic review was conducted, searching major medical databases including Medline, Embase, and The Cochrane Library.
- Included studies focused on hospital phototherapy for unconjugated hyperbilirubinemia in term and preterm infants.
- Data on intervention effectiveness, safety, and harms alerts from regulatory agencies were collected and analyzed.
Main Results:
- Fourteen studies met the inclusion criteria for the systematic review.
- The quality of evidence for various phototherapy interventions was evaluated using the GRADE system.
- Information regarding the effectiveness and safety of different phototherapy parameters was compiled.
Conclusions:
- The review provides comprehensive information on hospital phototherapy for neonatal jaundice.
- Findings relate to the effectiveness and safety of varying wavelengths, intensities, total doses, and commencement thresholds.
- This evidence supports clinical decision-making regarding phototherapy for unconjugated hyperbilirubinemia in newborns.
Introduction:
About 50% of term and 80% of preterm babies develop jaundice, which usually appears 2 to 4 days after birth, and resolves spontaneously after 1 to 2 weeks. Jaundice is caused by bilirubin deposition in the skin. Most jaundice in newborn infants is a result of increased red cell breakdown and decreased bilirubin excretion.
Methods And Outcomes:
We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of different wavelengths of light in hospital phototherapy as treatment for unconjugated hyperbilirubinaemia in term and preterm infants? What are the effects of different intensities of light in hospital phototherapy as treatment for unconjugated hyperbilirubinaemia in term and preterm infants? What are the effects of different total doses of light in hospital phototherapy as treatment for unconjugated hyperbilirubinaemia in term and preterm infants? What are the effects of starting hospital phototherapy at different thresholds in term and preterm infants? We searched Medline, Embase, The Cochrane Library, and other important databases up to January 2014 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Results:
Fourteen studies were included. We performed a GRADE evaluation of the quality of evidence for interventions.
Conclusions:
In this systematic review we present information relating to the effectiveness and safety of different wavelengths, intensities, total doses, and threshold for commencement of the following intervention: hospital phototherapy.
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Acne Infection
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Drug Dosing: Infants and Children
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...

